MACI Implantation matrix Ref.[50008] Active ingredients: Autologous chondrocytes

Source: European Medicines Agency (EU)  Revision Year: 2018  Publisher: Vericel Denmark ApS, Amaliegade 10, DK-1256 Copenhagen K, Denmark

Product name and form

MACI 500,000 to 1,000,000 cells/cm² implantation matrix.

Pharmaceutical Form

Implantation matrix.

The implant is an opaque, off-white membrane, seeded with chondrocytes, supplied in 18 ml of colourless solution in a dish.

Qualitative and quantitative composition

Each implant contains matrix applied characterised autologous cultured chondrocytes.

Characterised viable autologous chondrocytes expanded ex vivo expressing chondrocyte-specific marker genes, seeded onto a CE marked porcine derived Type I/III collagen membrane.

Each implantation matrix consists of characterised autologous chondrocytes on a 14.5 cm² Type I/III collagen membrane, at a density of 500,000 to 1,000,000 cells per cm², to be trimmed by the surgeon to the size and shape of the defect.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Autologous chondrocytes

Autologous chondrocyte implantation (ACI) is based on the extraction of the patient’s own chondrocytes isolated from healthy cartilage, their culture in vitro and their subsequent implantation into the cartilage defect. The implantation suspension is cultured and implanted as three-dimensional spheroids.

List of Excipients

Dulbecco’s Modified Eagles Medium (DMEM; Calcium Chloride anhydrous, Ferric Nitrate.9H2O, Potassium Chloride, Magnesium Sulphate anhydrous, Sodium Chloride, Sodium Bicarbonate, Potassium Phosphate Monobasic.H~2~O, D-Glucose, L-Arginine.HCl, L-Cystine.2HCl, L-Glutamine, Glycine, L-Histidine.HCl.H~2~O, L-Isoleucine, L-Leucine, L-Lysine.HCl, L-Methionine, L-Phenylalanine, L-Serine, L-Threonine, L-Tryptophan, L-Tyrosine.2Na.2H~2~O, L-Valine, D-Calcium Pantothenate, Choline Chloride, Folic Acid, i-Inositol, Niacinamide, Riboflavin, Thiamine.HCl, Pyridoxine.HCl) with 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid sodium (HEPES) adjusted for pH with HCl or NaOH and osmality with NaCl.

Pack sizes and marketing

MACI is shipped in custom-designed, sterile, sealed, clear polystyrene dishes.

Each dish contains 1 implantation matrix, held in place by a green polycarbonate x-ring and closed with a green polycarbonate cover for shipment.

Each dish is sealed in a gamma-irradiated clear plastic bag.

MACI is supplied in 1 to 2 dishes, which are placed into a 95kPa pouch (outer bag) with absorbent material for transport.

This package is enclosed in an outer carton insulated with ambient gel packs.

Marketing authorization holder

Vericel Denmark ApS, Amaliegade 10, DK-1256 Copenhagen K, Denmark

Marketing authorization dates and numbers

EU/1/13/847/001

Date of first authorisation: 27 June 2013

Drugs

Drug Countries
MACI Estonia, Ireland, Lithuania

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.